nodes	percent_of_prediction	percent_of_DWPC	metapath
Dutasteride—CYP3A5—Tamoxifen—pancreatic cancer	0.149	0.186	CbGbCtD
Dutasteride—CYP3A5—Erlotinib—pancreatic cancer	0.127	0.159	CbGbCtD
Dutasteride—CYP3A5—Irinotecan—pancreatic cancer	0.115	0.143	CbGbCtD
Dutasteride—CYP3A5—Docetaxel—pancreatic cancer	0.084	0.105	CbGbCtD
Dutasteride—CYP3A5—Sunitinib—pancreatic cancer	0.0836	0.104	CbGbCtD
Dutasteride—Breast cancer male—Tamoxifen—pancreatic cancer	0.0757	0.379	CcSEcCtD
Dutasteride—CYP3A4—Tamoxifen—pancreatic cancer	0.0582	0.0727	CbGbCtD
Dutasteride—CYP3A4—Erlotinib—pancreatic cancer	0.0495	0.0618	CbGbCtD
Dutasteride—CYP3A4—Irinotecan—pancreatic cancer	0.0447	0.0558	CbGbCtD
Dutasteride—CYP3A4—Docetaxel—pancreatic cancer	0.0327	0.0409	CbGbCtD
Dutasteride—CYP3A4—Sunitinib—pancreatic cancer	0.0326	0.0407	CbGbCtD
Dutasteride—CYP3A4—Doxorubicin—pancreatic cancer	0.0244	0.0305	CbGbCtD
Dutasteride—Loss of libido—Tamoxifen—pancreatic cancer	0.00785	0.0393	CcSEcCtD
Dutasteride—Breast cancer—Gemcitabine—pancreatic cancer	0.00683	0.0342	CcSEcCtD
Dutasteride—Breast cancer—Docetaxel—pancreatic cancer	0.00484	0.0243	CcSEcCtD
Dutasteride—Tenderness—Tamoxifen—pancreatic cancer	0.00415	0.0208	CcSEcCtD
Dutasteride—Breast pain—Tamoxifen—pancreatic cancer	0.00415	0.0208	CcSEcCtD
Dutasteride—Tenderness—Erlotinib—pancreatic cancer	0.00411	0.0206	CcSEcCtD
Dutasteride—Hyperaesthesia—Sunitinib—pancreatic cancer	0.00395	0.0198	CcSEcCtD
Dutasteride—Neoplasm malignant—Sunitinib—pancreatic cancer	0.00363	0.0182	CcSEcCtD
Dutasteride—Neoplasm—Tamoxifen—pancreatic cancer	0.00328	0.0164	CcSEcCtD
Dutasteride—Neoplasm malignant—Irinotecan—pancreatic cancer	0.00299	0.015	CcSEcCtD
Dutasteride—Neoplasm malignant—Gemcitabine—pancreatic cancer	0.00292	0.0146	CcSEcCtD
Dutasteride—Tenderness—Gemcitabine—pancreatic cancer	0.00285	0.0143	CcSEcCtD
Dutasteride—Tenderness—Fluorouracil—pancreatic cancer	0.00281	0.0141	CcSEcCtD
Dutasteride—Neoplasm—Sunitinib—pancreatic cancer	0.00281	0.0141	CcSEcCtD
Dutasteride—Neoplasm—Irinotecan—pancreatic cancer	0.00231	0.0116	CcSEcCtD
Dutasteride—Cardiac failure—Sunitinib—pancreatic cancer	0.00231	0.0116	CcSEcCtD
Dutasteride—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.00209	0.0105	CcSEcCtD
Dutasteride—Cardiac failure—Gemcitabine—pancreatic cancer	0.00185	0.00928	CcSEcCtD
Dutasteride—Cardiac failure—Fluorouracil—pancreatic cancer	0.00182	0.00912	CcSEcCtD
Dutasteride—Neoplasm—Docetaxel—pancreatic cancer	0.0016	0.008	CcSEcCtD
Dutasteride—Mental disorder—Erlotinib—pancreatic cancer	0.00158	0.0079	CcSEcCtD
Dutasteride—Hyperaesthesia—Epirubicin—pancreatic cancer	0.00152	0.00761	CcSEcCtD
Dutasteride—Angioedema—Tamoxifen—pancreatic cancer	0.00145	0.00725	CcSEcCtD
Dutasteride—Immune system disorder—Sunitinib—pancreatic cancer	0.00141	0.00705	CcSEcCtD
Dutasteride—Hyperaesthesia—Doxorubicin—pancreatic cancer	0.00141	0.00704	CcSEcCtD
Dutasteride—Neoplasm malignant—Epirubicin—pancreatic cancer	0.0014	0.00699	CcSEcCtD
Dutasteride—Breast pain—Epirubicin—pancreatic cancer	0.00137	0.00684	CcSEcCtD
Dutasteride—Mental disorder—Sunitinib—pancreatic cancer	0.00137	0.00684	CcSEcCtD
Dutasteride—Cardiac failure—Docetaxel—pancreatic cancer	0.00131	0.00658	CcSEcCtD
Dutasteride—Neoplasm malignant—Doxorubicin—pancreatic cancer	0.00129	0.00647	CcSEcCtD
Dutasteride—Breast pain—Doxorubicin—pancreatic cancer	0.00126	0.00633	CcSEcCtD
Dutasteride—Angioedema—Sunitinib—pancreatic cancer	0.00124	0.00621	CcSEcCtD
Dutasteride—Immune system disorder—Irinotecan—pancreatic cancer	0.00116	0.00581	CcSEcCtD
Dutasteride—Breast disorder—Docetaxel—pancreatic cancer	0.00116	0.00581	CcSEcCtD
Dutasteride—Immune system disorder—Gemcitabine—pancreatic cancer	0.00113	0.00566	CcSEcCtD
Dutasteride—Neoplasm—Epirubicin—pancreatic cancer	0.00108	0.0054	CcSEcCtD
Dutasteride—Urticaria—Tamoxifen—pancreatic cancer	0.00103	0.00514	CcSEcCtD
Dutasteride—Neoplasm—Doxorubicin—pancreatic cancer	0.000997	0.005	CcSEcCtD
Dutasteride—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000953	0.00477	CcSEcCtD
Dutasteride—Pruritus—Tamoxifen—pancreatic cancer	0.000915	0.00458	CcSEcCtD
Dutasteride—Pruritus—Erlotinib—pancreatic cancer	0.000905	0.00453	CcSEcCtD
Dutasteride—Cardiac failure—Epirubicin—pancreatic cancer	0.000887	0.00444	CcSEcCtD
Dutasteride—Dizziness—Tamoxifen—pancreatic cancer	0.000855	0.00428	CcSEcCtD
Dutasteride—Dizziness—Erlotinib—pancreatic cancer	0.000846	0.00424	CcSEcCtD
Dutasteride—Cardiac failure—Doxorubicin—pancreatic cancer	0.00082	0.00411	CcSEcCtD
Dutasteride—Hypersensitivity—Sunitinib—pancreatic cancer	0.000816	0.00409	CcSEcCtD
Dutasteride—Rash—Tamoxifen—pancreatic cancer	0.000815	0.00408	CcSEcCtD
Dutasteride—Dermatitis—Tamoxifen—pancreatic cancer	0.000814	0.00408	CcSEcCtD
Dutasteride—Rash—Erlotinib—pancreatic cancer	0.000807	0.00404	CcSEcCtD
Dutasteride—Dermatitis—Erlotinib—pancreatic cancer	0.000806	0.00404	CcSEcCtD
Dutasteride—Immune system disorder—Docetaxel—pancreatic cancer	0.000802	0.00402	CcSEcCtD
Dutasteride—Pruritus—Sunitinib—pancreatic cancer	0.000783	0.00392	CcSEcCtD
Dutasteride—Breast disorder—Epirubicin—pancreatic cancer	0.000782	0.00392	CcSEcCtD
Dutasteride—Mental disorder—Docetaxel—pancreatic cancer	0.000778	0.00389	CcSEcCtD
Dutasteride—Dizziness—Sunitinib—pancreatic cancer	0.000732	0.00367	CcSEcCtD
Dutasteride—Breast disorder—Doxorubicin—pancreatic cancer	0.000724	0.00362	CcSEcCtD
Dutasteride—Rash—Sunitinib—pancreatic cancer	0.000698	0.0035	CcSEcCtD
Dutasteride—Dermatitis—Sunitinib—pancreatic cancer	0.000698	0.00349	CcSEcCtD
Dutasteride—Urticaria—Fluorouracil—pancreatic cancer	0.000694	0.00348	CcSEcCtD
Dutasteride—Hypersensitivity—Irinotecan—pancreatic cancer	0.000672	0.00337	CcSEcCtD
Dutasteride—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000644	0.00322	CcSEcCtD
Dutasteride—Pruritus—Gemcitabine—pancreatic cancer	0.000629	0.00315	CcSEcCtD
Dutasteride—Pruritus—Fluorouracil—pancreatic cancer	0.000618	0.0031	CcSEcCtD
Dutasteride—Dizziness—Irinotecan—pancreatic cancer	0.000603	0.00302	CcSEcCtD
Dutasteride—Dizziness—Fluorouracil—pancreatic cancer	0.000578	0.00289	CcSEcCtD
Dutasteride—Rash—Irinotecan—pancreatic cancer	0.000575	0.00288	CcSEcCtD
Dutasteride—Dermatitis—Irinotecan—pancreatic cancer	0.000575	0.00288	CcSEcCtD
Dutasteride—Rash—Gemcitabine—pancreatic cancer	0.00056	0.00281	CcSEcCtD
Dutasteride—Dermatitis—Gemcitabine—pancreatic cancer	0.00056	0.0028	CcSEcCtD
Dutasteride—Rash—Fluorouracil—pancreatic cancer	0.000551	0.00276	CcSEcCtD
Dutasteride—Dermatitis—Fluorouracil—pancreatic cancer	0.00055	0.00276	CcSEcCtD
Dutasteride—Immune system disorder—Epirubicin—pancreatic cancer	0.000541	0.00271	CcSEcCtD
Dutasteride—Mental disorder—Epirubicin—pancreatic cancer	0.000524	0.00263	CcSEcCtD
Dutasteride—Immune system disorder—Doxorubicin—pancreatic cancer	0.0005	0.00251	CcSEcCtD
Dutasteride—Mental disorder—Doxorubicin—pancreatic cancer	0.000485	0.00243	CcSEcCtD
Dutasteride—Hypersensitivity—Docetaxel—pancreatic cancer	0.000465	0.00233	CcSEcCtD
Dutasteride—Pruritus—Docetaxel—pancreatic cancer	0.000446	0.00223	CcSEcCtD
Dutasteride—Dizziness—Docetaxel—pancreatic cancer	0.000417	0.00209	CcSEcCtD
Dutasteride—Rash—Docetaxel—pancreatic cancer	0.000398	0.00199	CcSEcCtD
Dutasteride—Dermatitis—Docetaxel—pancreatic cancer	0.000397	0.00199	CcSEcCtD
Dutasteride—Urticaria—Epirubicin—pancreatic cancer	0.000338	0.00169	CcSEcCtD
Dutasteride—Hypersensitivity—Epirubicin—pancreatic cancer	0.000313	0.00157	CcSEcCtD
Dutasteride—Urticaria—Doxorubicin—pancreatic cancer	0.000313	0.00157	CcSEcCtD
Dutasteride—Pruritus—Epirubicin—pancreatic cancer	0.000301	0.00151	CcSEcCtD
Dutasteride—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00029	0.00145	CcSEcCtD
Dutasteride—Dizziness—Epirubicin—pancreatic cancer	0.000281	0.00141	CcSEcCtD
Dutasteride—Pruritus—Doxorubicin—pancreatic cancer	0.000278	0.00139	CcSEcCtD
Dutasteride—Rash—Epirubicin—pancreatic cancer	0.000268	0.00134	CcSEcCtD
Dutasteride—Dermatitis—Epirubicin—pancreatic cancer	0.000268	0.00134	CcSEcCtD
Dutasteride—Dizziness—Doxorubicin—pancreatic cancer	0.00026	0.0013	CcSEcCtD
Dutasteride—Rash—Doxorubicin—pancreatic cancer	0.000248	0.00124	CcSEcCtD
Dutasteride—Dermatitis—Doxorubicin—pancreatic cancer	0.000248	0.00124	CcSEcCtD
